Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0KL4K
|
||||
Former ID |
DIB020243
|
||||
Drug Name |
LSP4-2022
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [541811] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H18NO8P
|
||||
InChI |
InChI=1S/C13H18NO8P/c14-10(12(17)18)5-6-23(20,21)13(19)8-1-3-9(4-2-8)22-7-11(15)16/h1-4,10,13,19H,5-7,14H2,(H,15,16)(H,17,18)(H,20,21)/t10-,13?/m0/s1
|
||||
InChIKey |
BGOFVWMHMQISHB-NKUHCKNESA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | mGlu6 receptor | Target Info | Agonist | [531757] | |
Metabotropic glutamate receptor 4 | Target Info | Agonist | [531757] | ||
Metabotropic glutamate receptor 7 | Target Info | Agonist | [531757] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Metabotropic glutamate receptor group III pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Metabotropic glutamate receptor group III pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.